Results 1 to 10 of about 9,248 (241)

Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs

open access: yesMolecules
The accumulation of senescent cells is a major contributor to aging and various age-related diseases, making developing senolytic compounds that are capable of clearing these cells an important area of research. However, progress has been hampered by the
Shao-Xing Dai, Min Xu, Li Jinjun
exaly   +5 more sources

Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics?

open access: yesBiomolecules
Aging is a predominant risk factor for cardiovascular diseases. There is evidence demonstrating that senescent cells not only play a significant role in organism aging but also contribute to the pathogenesis of cardiovascular diseases in younger ages ...
Zhihong Yang   +2 more
doaj   +2 more sources

Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice

open access: yesFrontiers in Medicine
IntroductionChronic obstructive pulmonary disease (COPD) is a disease of accelerated lung aging, with increased numbers of senescent cells found within the COPD Lung.
Jonathan R. Baker   +6 more
doaj   +2 more sources

Senolytic drugs: from discovery to translation [PDF]

open access: yesJournal of Internal Medicine, 2020
Senolytics are a class of drugs that selectively clear senescent cells (SC). The first senolytic drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis‐driven approach.
J. Kirkland, T. Tchkonia
semanticscholar   +3 more sources

Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy

open access: yesEMBO Molecular Medicine
Glioblastomas (GBM) are routinely treated with high doses of ionizing radiation (IR), yet these tumors recur quickly, and the recurrent tumors are highly therapy resistant.
Andrea Gilbert   +2 more
exaly   +2 more sources

A pipeline for senolytics

open access: yesThe Journal of Clinical Investigation
There is intense interest in identifying compounds that selectively kill senescent cells, termed senolytics, for ameliorating age-related comorbidities.
Sundeep Khosla
doaj   +3 more sources

Senolytic Therapy Enabled by Senescent Cell‐Sensitive Biomimetic Melanin Nano‐Senolytics

open access: yesAdvanced Healthcare Materials
Cellular senescence is a significant risk factor for aging and age‐related diseases (ARD). The canonical senolytics Dasatinib and Quercetin (DQ) have shown promise in clearing senescent cells (SnCs); however, the lack of selectivity poses a challenge in ...
Hairui Zhang   +10 more
semanticscholar   +3 more sources

Failure of senolytic treatment to prevent cognitive decline in a female rodent model of aging

open access: yesFrontiers in Aging Neuroscience
There are sex differences in vulnerability and resilience to the stressors of aging and subsequent age-related cognitive decline. Cellular senescence occurs as a response to damaging or stress-inducing stimuli.
Thomas C Foster   +2 more
exaly   +3 more sources

Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells

open access: yesFrontiers in Cell and Developmental Biology
Malignant Melanoma that resists immunotherapy remains the deadliest form of skin cancer owing to poor clinically lasting responses. Alternative like genotoxic or targeted chemotherapy trigger various cancer cell fates after treatment including cell death
Nicolas Malaquin   +2 more
exaly   +3 more sources

Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age

open access: yesAging Cell, 2023
Aging results in an elevated burden of senescent cells, senescence‐associated secretory phenotype (SASP), and tissue infiltration of immune cells contributing to chronic low‐grade inflammation and a host of age‐related diseases.
M. Islam   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy